Clinical Trials
How clinical trials actually work — how they are designed, how people are recruited and kept informed, and what good practice looks like. Written for anyone who wants to understand the machinery, whether you are considering a trial or running one.
-
Patient Engagement or Industry Buzzword? Let’s Get Real
Read more: Patient Engagement or Industry Buzzword? Let’s Get RealA candid critique of tokenistic patient engagement, exposing sponsor blind spots and backing it with recruitment cost data, then calling for patient…
-
Uniting Stakeholders in Rare Disease Trials – We Cannot Innovate Alone
Read more: Uniting Stakeholders in Rare Disease Trials – We Cannot Innovate AloneArgues rare disease trial success requires patients, pharma, regulators, and researchers working as true partners, with shared goals, clear roles, and sustained…
-
Rare Disease Clinical Trials: Pharma’s Risk Perspective
Read more: Rare Disease Clinical Trials: Pharma’s Risk PerspectiveAnalyzes the recruitment, retention, regulatory, and commercial risks pharma faces in rare disease trials, and how real-world evidence, AI forecasting, adaptive designs,…
-
Every Patient’s Voice Shapes Medical Research
Read more: Every Patient’s Voice Shapes Medical ResearchRewritten Aug 2026 in a direct second-person voice. Explains why lived experience is research data, how real-world evidence and pharmacovigilance extend what…
-
How Simplified Trial Processes Can Increase Participation
Read more: How Simplified Trial Processes Can Increase ParticipationPairs a BCG analysis of rising trial complexity across 16,000 protocols with practical arguments for simplification: remote participation, plain-language consent, streamlined recruitment,…
-
Making Patients Heard Throughout the Research Journey
Read more: Making Patients Heard Throughout the Research JourneyOpens with why patients withdraw through a thousand tiny cuts, then makes the case for embedding patient input from protocol design through…
-
Jargon Hurts Trust Between Trials and Communities
Read more: Jargon Hurts Trust Between Trials and CommunitiesPairs survey data on how badly patients misunderstand medical jargon with an argument that plain-language communication is essential for trust, consent, recruitment,…
-
Assessing Adherence to Strengthen Trial Results
Read more: Assessing Adherence to Strengthen Trial ResultsQuantifies how non-adherence inflates trial cost and sample size, with delay costs of up to $8M per day, and details monitoring tools…
-
Rare Diseases Deserve Tailored Clinical Trial Solutions
Read more: Rare Diseases Deserve Tailored Clinical Trial SolutionsRewritten Aug 2026 for patients: the trial three states away as the central problem. Explains why rare disease research is harder (small…
-
Simplifying Trials Helps Patients Feel Confident Participating
Read more: Simplifying Trials Helps Patients Feel Confident ParticipatingMakes the case that plain-language communication and simplified consent materials build patient confidence, broaden inclusion, and improve both recruitment and retention in…